Bukwang Pharmaceutical Co., Ltd. (KRX:003000)

Bukwang Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 20, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	389,232	314,207	417,573	598,978	883,065	1,924,170
Market Cap Growth	16.40%	-24.75%	-30.29%	-32.17%	-54.11%	109.52%
Enterprise Value	252,327	280,401	368,683	519,044	826,852	1,868,498
Last Close Price	3945.00	4192.97	5572.36	7993.14	11784.17	25475.67
PE Ratio	30.21	-	-	-	-	-
Forward PE	-	58.75	58.75	58.75	58.75	58.75
PS Ratio	2.11	1.96	3.32	3.14	4.84	11.34
PB Ratio	1.14	1.29	1.78	2.20	3.15	7.10
P/TBV Ratio	1.17	1.32	1.93	2.34	3.36	7.65
P/FCF Ratio	22.91	9.69	-	49.25	34.31	-
P/OCF Ratio	17.25	9.14	-	36.39	33.29	2660.75
EV/Sales Ratio	1.37	1.75	2.93	2.72	4.53	11.01
EV/EBITDA Ratio	19.57	48.99	-	106.23	79.01	183.44
EV/EBIT Ratio	32.90	173.34	-	-	147.08	463.86
EV/FCF Ratio	14.85	8.65	-	42.67	32.12	-
Debt / Equity Ratio	0.24	0.33	0.34	0.00	0.01	0.08
Debt / EBITDA Ratio	6.09	13.88	-	0.19	0.15	2.12
Debt / FCF Ratio	4.72	2.45	-	0.08	0.06	-
Asset Turnover	0.45	0.40	0.30	0.48	0.46	0.43
Inventory Turnover	2.10	1.75	1.66	2.87	2.36	2.06
Quick Ratio	3.71	4.37	1.93	3.90	4.79	3.16
Current Ratio	4.60	5.76	2.61	4.90	5.95	4.06
Return on Equity (ROE)	3.36%	-1.45%	-13.60%	-1.54%	-1.01%	-3.38%
Return on Assets (ROA)	1.21%	0.25%	-5.65%	-0.04%	0.88%	0.64%
Return on Capital (ROIC)	1.36%	0.32%	-7.99%	-0.05%	1.22%	0.81%
Return on Capital Employed (ROCE)	2.00%	0.50%	-11.30%	-0.10%	1.60%	1.20%
Earnings Yield	2.50%	-0.84%	-7.50%	-0.41%	-0.10%	-0.37%
FCF Yield	4.37%	10.32%	-2.92%	2.03%	2.92%	-0.06%
Buyback Yield / Dilution	-9.11%	-	-	0.01%	0.25%	4.24%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.